Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2
According to the Bloomberg story I read, Dr Schwan said Roche was looking at small to medium-sized acquistions although he believes biotech valuations are too high.
Dr Schwan, though, refused to comment when the Bloomberg hack tried to elicit a denial or confirmation by asking him spefically about Roche's interest in BioMarin.
Date:Thursday, 21 July 2016 9:46 pm
